baha the information company baha WebStation Terminal contact us Request free demo

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Free License - non-commercial use only

Region

Time Zone

UK
history
open
Sign Up / Login

For full-featured experience, please enable JavaScript.

BNP Paribas Knock-Out EVT/ DE000PC8YLY8 /

24/05/2024 21:20:31	Chg.-0.200	Bid21:58:01	Ask24/05/2024	Underlying	Strike price	Expiration date	Option type
0.610EUR	-24.69%	0.620 Bid Size: 4,839	- Ask Size: -	EVOTEC SE INH O.N.	8.5545 EUR	31/12/2078	Call

GlobeNewswire 14/05 CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease

GlobeNewswire 11/12/2023 Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune c...

GlobeNewswire 07/11/2023 Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline

GlobeNewswire 20/08/2020 CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease

GlobeNewswire 07/02/2019 Evotec and Galapagos enter into collaboration in the field of fibrosis

GlobeNewswire 07/02/2019 Evotec and Galapagos enter into collaboration in the field of fibrosis

GlobeNewswire 15/02/2018 EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE

GlobeNewswire 08/01/2018 APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi

GlobeNewswire 14/09/2017 MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO

GlobeNewswire 29/11/2011 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...

GlobeNewswire 10/11/2011 Evotec reports nine months results: Upside materialising

GlobeNewswire 03/11/2011 Evotec to Report Third Quarter Results on 10 November 2011

GlobeNewswire 27/10/2011 Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi

GlobeNewswire 20/10/2011 Evotec and APEIRON Biologics start next project on the Cbl-b target

GlobeNewswire 05/10/2011 Evotec announces second multi-target collaboration with UCB

GlobeNewswire 29/09/2011 Evotec acquires remaining 30% of Indian Joint Venture from DIL

GlobeNewswire 09/09/2011 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...

GlobeNewswire 05/09/2011 Evotec and Roche agree to develop compound that could slow the progression of Alzheimer's disease

GlobeNewswire 05/09/2011 Evotec AG:Ad hoc:Evotec and Roche agree to develop compound that could slow the progression of Alzhe...

GlobeNewswire 18/08/2011 Evotec Receives Pre-clinical Milestone Payment as Part of its Discovery Alliance with Boehringer In...

GlobeNewswire 11/08/2011 Evotec reports 34% revenue and profitable earnings growth; revenue guidance raised

GlobeNewswire 11/08/2011 Evotec partners P2X7 antagonist programme, EVT 401, to a top tier global animal health company

GlobeNewswire 04/08/2011 Evotec to Report Second Quarter 2011 Results on 11 August 2011

GlobeNewswire 07/07/2011 Evotec announces multi-target collaboration with UCB in neurodegenerative and neurological diseases

GlobeNewswire 30/06/2011 Total voting rights:Evotec AG:Evotec AG: Publication pursuant to §26a WpHG (the German Securities Tr...